DE SANCTIS, Giuseppe Maria
 Distribuzione geografica
Continente #
NA - Nord America 466
EU - Europa 147
AS - Asia 85
AF - Africa 1
SA - Sud America 1
Totale 700
Nazione #
US - Stati Uniti d'America 459
IT - Italia 77
SG - Singapore 40
IN - India 29
SE - Svezia 22
BG - Bulgaria 10
CN - Cina 10
DE - Germania 7
CA - Canada 5
FI - Finlandia 5
ID - Indonesia 5
RO - Romania 4
RU - Federazione Russa 4
BE - Belgio 3
NL - Olanda 3
RS - Serbia 3
GB - Regno Unito 2
IE - Irlanda 2
UA - Ucraina 2
AR - Argentina 1
AT - Austria 1
BZ - Belize 1
FR - Francia 1
HK - Hong Kong 1
LT - Lituania 1
MX - Messico 1
TG - Togo 1
Totale 700
Città #
Fairfield 79
Ashburn 47
Chandler 46
Singapore 34
Rome 29
Dearborn 27
Cambridge 24
Seattle 24
Woodbridge 22
Wilmington 21
Houston 18
Princeton 13
Santa Clara 12
Sofia 10
Ann Arbor 9
Plano 8
Millbury 7
San Diego 6
Jakarta 5
Milan 5
Boston 4
Lawrence 4
Pune 4
San Paolo di Civitate 4
Albano Laziale 3
Andover 3
Beijing 3
Brussels 3
Helsinki 3
Selevac 3
Barletta 2
Brescia 2
Dublin 2
Hefei 2
Livorno 2
North Vancouver 2
Norwalk 2
San Jose 2
Toronto 2
Turin 2
Belize City 1
Bühl 1
Catania 1
Chengdu 1
Delhi 1
Des Moines 1
Federal 1
Florence 1
Frankfurt am Main 1
Fuzhou 1
Hong Kong 1
Jinhua 1
Lomé 1
London 1
Los Angeles 1
Messina 1
Mexico City 1
Moscow 1
Nanchang 1
Nuremberg 1
Ottawa 1
Phoenix 1
Prescot 1
Roseto Degli Abruzzi 1
San Mateo 1
Shimla 1
Yinchuan 1
Totale 527
Nome #
HCC in the era of direct-acting antiviral agents (DAAs): surgical and other curative or palliative strategies in the elderly 99
Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis 91
Hepatitis Delta Antigen (HDAg) is characterized by an extensive degree of genetic variability that correlates with elevated levels of serum HDV-RNA 85
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets 82
Long-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitis. 75
The circulation of specific vaccine-escape HBsAg mutations in HBV genotype D infected patients correlates with high viremia and affects HBsAg detection and quantification 70
In HBeAg-negative chronic HBV infection, HBsAg levels profoundly vary among different HBV-genotypes and can be influenced by the degree of HBsAg variability: can quantitative HBsAg truly reflect intra-hepatic HBV reservoir? 70
HBV-HDV Co-Infection Constrains HBV Genetic Evolution in HBsAg 69
Differente reattività verso le proteine di HCV in paziente con danno epatico da HCV. 40
Surgical resection is superior to TACE in the treatment of HCC in a well selected cohort of BCLC-B elderly patients—A retrospective observational study 32
Unexpected rise in the circulation of complex hbv variants enriched of hbsag vaccine-escape mutationshbvn HB genotype-d. Potential impact on hbsag detection/quantification and vaccination strategies 31
Prevalence of hepatitis d virus infection in central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication 10
Totale 754
Categoria #
all - tutte 2.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.410


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202072 0 0 0 0 0 0 24 13 13 14 4 4
2020/202139 6 3 5 0 0 0 0 2 7 2 0 14
2021/2022130 10 1 10 8 12 3 5 9 11 7 31 23
2022/2023144 24 25 12 8 14 16 3 6 19 3 5 9
2023/2024100 11 8 4 4 8 25 7 10 1 17 1 4
2024/202585 4 11 17 9 16 24 4 0 0 0 0 0
Totale 754